Parrot David
All 5 shown
- Scribe Therapeutics, Inc. Chief financial officer109,426 sharesGrant
- Scribe Therapeutics, Inc. Chief financial officer109,426 sharesGrant
- Scribe Therapeutics, Inc. Chief financial officer$19,995Open-market buy
- Scribe Therapeutics, Inc. Chief financial officer$19,995Open-market buy
- Scribe Therapeutics, Inc. Chief financial officer8,909 sharesGrant